Delivery Order SPE2DB22D2211-SPE2DB25FSFWE
- Not listed
- The Defense Logistics Agency awarded a $5,652.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 8, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's substantial Indefinite Delivery Contract with...
- The Defense Logistics Agency has awarded a delivery order valued at $1,452.55 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,548.95 for Mounjaro 7.5 mg/0.5 mL pen injectors on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $4,531.80. This firm fixed-price delivery order, issued on June 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation and was competitively awarded. Performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $11,766.11 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 11, 2025, with completion scheduled for September 12, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $9,251.06 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on September 17, 2025, with completion scheduled for September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $1,904.63 delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing as the pricing mechanism. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $14,094.91 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication, consistent with AmerisourceBergen's established...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFWEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,883.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 24, 2025, with completion targeted for September 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. Mounjaro is a brand-name pharmaceutical used for diabetes management, reflecting the critical role that AmerisourceBergen plays as a primary pharmaceutical distributor for federal military and veteran healthcare systems. As a child contract under the comprehensive IDC vehicle, this delivery order demonstrates the company's capability to fulfill federal medical supply requirements through competitive procurement. AmerisourceBergen's pharmaceutical prime vendor relationship with DLA provides a flexible procurement mechanism to supply a broad range of medications and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 9/24/25 |